A new trading day began on Tuesday, with Relmada Therapeutics Inc (NASDAQ: RLMD) stock price up 25.91% from the previous day of trading, before settling in for the closing price of $2.2. RLMD’s price has ranged from $0.24 to $3.67 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 0.68%. Meanwhile, its annual earnings per share averaged 37.80%. With a float of $23.12 million, this company’s outstanding shares have now reached $33.19 million.
Relmada Therapeutics Inc (RLMD) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Relmada Therapeutics Inc is 30.34%, while institutional ownership is 24.83%. The most recent insider transaction that took place on Aug 27 ’25, was worth 86,735. In this transaction Chief Executive Officer of this company bought 129,455 shares at a rate of $0.67, taking the stock ownership to the 944,024 shares. Before that another transaction happened on Aug 26 ’25, when Company’s Chief Executive Officer bought 80,545 for $0.62, making the entire transaction worth $49,938. This insider now owns 814,569 shares in total.
Relmada Therapeutics Inc (RLMD) Performance Highlights and Predictions
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.59 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months).
Relmada Therapeutics Inc (NASDAQ: RLMD) Trading Performance Indicators
Here are Relmada Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.21, a number that is poised to hit -0.42 in the next quarter
Technical Analysis of Relmada Therapeutics Inc (RLMD)
The latest stats from [Relmada Therapeutics Inc, RLMD] show that its last 5-days average volume of 4.63 million was superior to 1.18 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 57.29%.
During the past 100 days, Relmada Therapeutics Inc’s (RLMD) raw stochastic average was set at 96.98%, which indicates a significant increase from 96.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.23 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.85, while its 200-day Moving Average is $0.82. Now, the first resistance to watch is $2.99. This is followed by the second major resistance level at $3.21. The third major resistance level sits at $3.61. If the price goes on to break the first support level at $2.37, it is likely to go to the next support level at $1.97. Assuming the price breaks the second support level, the third support level stands at $1.75.
Relmada Therapeutics Inc (NASDAQ: RLMD) Key Stats
With a market capitalization of 91.94 million, the company has a total of 33,192K Shares Outstanding. Currently, annual sales are 0 K while annual income is -79,980 K. The company’s previous quarter sales were 0 K while its latest quarter income was -9,870 K.
